Clinical Trials
10 trialsNCT06114108 2026-04-02
salVage
Swiss Cancer Institute
Phase NA Recruiting
NCT06918132 2026-02-24
N-PLANC
Mayo Clinic
Phase 2 Recruiting
NCT06810609 2026-01-27
InDuRanS
University Hospital, Bonn
Phase 2 Recruiting
NCT07073365 2025-12-30
BOOST
Pusan National University Hospital
Phase 2 Recruiting
NCT07264647 2025-12-04
Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)
Fondazione Ricerca Traslazionale
Phase 2 Recruiting
NCT06939127 2025-04-22
Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB NSCLC
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT06908070 2025-04-03
CROWD
Amsterdam UMC, location VUmc
Phase 4 Recruiting
NCT05766800 2024-09-19
Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Recruiting
NCT06534489 2024-08-02
Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment
Ruijin Hospital
Recruiting
NCT04875585 2022-08-24
INNWOP1
Medical University Innsbruck
Phase 2 Recruiting